Regarding p16 expression, it was significantly associated with tumor site, risk category, mitotic index, local recurrence, distant metastasis, lymph node involvement, and the expression of CD117, BCL2, p53, and Cyclin D1. The gene discussed is CDKN2A; the disease is neoplasm.